Filing Flows › BeOne Medicines (ONC) › Free cash flow
BeOne Medicines (ONC) free cash flow by quarter
BeOne Medicines' free cash flow was $474M in Q3 2026 (third quarter 2026), +9% from Q2 2026. Over the last 6 quarters it ranged from $161M (Q1 2026) to $474M (Q3 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $474M | +9% | +34% |
| Q2 2026 | $435M | +171% | +98% |
| Q1 2026 | $161M | -58% | — |
| Q4 2025 | $380M | +7% | — |
| Q3 2025 | $354M | +61% | — |
| Q2 2025 | $220M | — | — |
Q3 2026 at a glance
BeOne Medicines, Q3 2026: revenue $1.9B (+34% year over year), operating margin 22.2%, net earnings $385M, operating cash flow $509M. The chart follows the revenue to costs, profit and cash.
Questions
What is BeOne Medicines' free cash flow?
BeOne Medicines' free cash flow was $474M in Q3 2026 (third quarter 2026), +9% from Q2 2026.
How has BeOne Medicines' free cash flow changed?
Over the last 6 quarters it ranged from $161M (Q1 2026) to $474M (Q3 2026).